chrX-14844672-C-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001018113.3(FANCB):​c.1996G>A​(p.Gly666Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00084 in 1,208,885 control chromosomes in the GnomAD database, including 7 homozygotes. There are 276 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0032 ( 1 hom., 103 hem., cov: 23)
Exomes 𝑓: 0.00060 ( 6 hom. 173 hem. )

Consequence

FANCB
NM_001018113.3 missense

Scores

16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.455
Variant links:
Genes affected
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0074588656).
BP6
Variant X-14844672-C-T is Benign according to our data. Variant chrX-14844672-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 246612.We mark this variant Likely_benign, oryginal submissions are: {Benign=3, Uncertain_significance=1}. Variant chrX-14844672-C-T is described in Lovd as [Likely_benign]. Variant chrX-14844672-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00317 (353/111523) while in subpopulation AFR AF= 0.0104 (319/30687). AF 95% confidence interval is 0.00946. There are 1 homozygotes in gnomad4. There are 103 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 103 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FANCBNM_001018113.3 linkuse as main transcriptc.1996G>A p.Gly666Ser missense_variant 9/10 ENST00000650831.1 NP_001018123.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FANCBENST00000650831.1 linkuse as main transcriptc.1996G>A p.Gly666Ser missense_variant 9/10 NM_001018113.3 ENSP00000498215 P2

Frequencies

GnomAD3 genomes
AF:
0.00311
AC:
347
AN:
111473
Hom.:
1
Cov.:
23
AF XY:
0.00291
AC XY:
98
AN XY:
33725
show subpopulations
Gnomad AFR
AF:
0.0102
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000476
Gnomad ASJ
AF:
0.00719
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000943
Gnomad OTH
AF:
0.00334
GnomAD3 exomes
AF:
0.00116
AC:
212
AN:
183142
Hom.:
0
AF XY:
0.000856
AC XY:
58
AN XY:
67780
show subpopulations
Gnomad AFR exome
AF:
0.0109
Gnomad AMR exome
AF:
0.000255
Gnomad ASJ exome
AF:
0.00601
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000159
Gnomad OTH exome
AF:
0.000888
GnomAD4 exome
AF:
0.000604
AC:
663
AN:
1097362
Hom.:
6
Cov.:
30
AF XY:
0.000477
AC XY:
173
AN XY:
362772
show subpopulations
Gnomad4 AFR exome
AF:
0.0124
Gnomad4 AMR exome
AF:
0.000455
Gnomad4 ASJ exome
AF:
0.00645
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000370
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000107
Gnomad4 OTH exome
AF:
0.00217
GnomAD4 genome
AF:
0.00317
AC:
353
AN:
111523
Hom.:
1
Cov.:
23
AF XY:
0.00305
AC XY:
103
AN XY:
33785
show subpopulations
Gnomad4 AFR
AF:
0.0104
Gnomad4 AMR
AF:
0.000476
Gnomad4 ASJ
AF:
0.00719
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000943
Gnomad4 OTH
AF:
0.00329
Alfa
AF:
0.000649
Hom.:
29
Bravo
AF:
0.00367
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0112
AC:
43
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.00114
AC:
139
EpiCase
AF:
0.000109
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoNov 19, 2018- -
History of neurodevelopmental disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 16, 2013Co-segregation data for this variant is currently unavailable.This variant has not been detected in conjunction with a pathogenic mutation to date.This variant was previously reported in the SNPDatabase as rs145110602. Based on data from the NHLBI Exome Sequencing Project (ESP), the A-allele has an overall frequency of approximately 0.25% (5/1997) total male alleles studied and but was not observed in the homozygous state out of 3381females studied. The A-allele was observed in 0.96% (5/522) African American male alleles but was absent out of 1475 European American male alleles studied. Based on data from the 1000 Genomes Project, the A-allele has an overall frequency of approximately 2/1048 (0.19%) and the highest frequency was in 2/48 (4.17%) African-American SW male chromosomes studied.This amino acid position is not conserved on species alignment.This alteration is predicted to be benign with a score of 0.002 (sensitivity: 0.99; specificity: 0.17)This alteration is predicted to be tolerated with a score of 0.390 (conservation: 2.57) -
Fanconi anemia complementation group B Benign:1
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Fanconi anemia Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
FANCB-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 18, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided Benign:1
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
1.9
DANN
Benign
0.40
DEOGEN2
Benign
0.062
T;T;T
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.38
T;.;T
MetaRNN
Benign
0.0075
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.85
L;L;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-0.70
N;N;N
REVEL
Benign
0.033
Sift
Benign
0.56
T;T;T
Sift4G
Benign
0.78
T;T;T
Polyphen
0.098
B;B;.
Vest4
0.16
MVP
0.21
MPC
0.10
ClinPred
0.0017
T
GERP RS
-1.1
Varity_R
0.041

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.16
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145110602; hg19: chrX-14862794; COSMIC: COSV60759880; API